Vanin 1 Gene Role in Modulation of iNOS/MCP-1/TGF-β1 Signaling Pathway in Obese Diabetic Patients

Yasser O Mosaad,Mohammed Abdalla Hussein,Hayam Ateyya,Ahmed H Mohamed,Ali A Ali,Alaa Ramadan Youssuf,Michael Wink,Amal A El-Kholy

DOI: https://doi.org/10.2147/JIR.S386506

IF: 4.5

2022-12-14

Journal of Inflammation Research

Abstract:Yasser O Mosaad, 1 Mohammed Abdalla Hussein, 2 Hayam Ateyya, 3, 4 Ahmed H Mohamed, 5 Ali A Ali, 6 Alaa Ramadan Youssuf, 7 Michael Wink, 8 Amal A El-Kholy 9 1 Department of Pharmacy, Practice & Clinical Pharmacy, Faculty of Pharmacy, Future University, Cairo, Egypt; 2 Department of Biotechnology, Faculty of Applied Health Science, October 6th University, October 6th City, Egypt; 3 Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt; 4 Department of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Future University, Cairo, Egypt; 5 Department of Radiology and Medical Imaging, Faculty of Applied Health Science Technology, October 6th University, October 6th City, Egypt; 6 Food Sciences Department, Faculty of Agriculture, Ain Shams University, Cairo, Egypt; 7 Consultant and Head of Cardiology Department, AL-AHRAR Teaching Hospital, Zagazig University, Zagazig, Egypt; 8 Heidelberg University, Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany; 9 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt Correspondence: Mohammed Abdalla Hussein, Faculty of Applied Health Sciences Technology, October 6th University, October 6th City, Egypt, Tel +20 1224832580, Email Introduction: Cysteamine, a powerful endogenous antioxidant, is produced mostly by the vanin-1 with pantetheinase activity. With regard to glycemic, inflammatory, and redox factors, the current study sought to evaluate the association between the expression of the vanin-1 gene, oxidative stress, and inflammatory and iNOS signaling pathway in obese diabetic patients. Methods: We enrolled 67 male subjects with an average age of 53.5 ± 5.0 years, divided into 4 groups according to the WHO guideline. We determined their plasma levels of glucose, insulin, IRI, HbA1c, TC, TG, HDL-C, TNF- α, MCP-1, TGF-β 1, SOD, CAT, and TBARs, as well as expression of the iNOS and Vanin1 genes. Results: Overweight and obese class I and II diabetics had significantly higher levels of plasma glucose, insulin, HbA1c, TNF-α, MCP-1, TGF-β 1, CAT, and TBAR as well as iNOS and vanin-1 gene expression compared to healthy control individuals. In addition, as compared to healthy control individuals, overweight obese class I and II diabetics' plasma HDL-C levels and blood SOD activity were significantly lower. In addition, ultrasound and computed tomography showed that the presence of a mild obscuring fatty liver with mild hepatic echogenicity appeared in overweight, class I and II obese diabetic patients. Conclusion: These findings provide important information for understanding the correlation between Vanin 1 and glycemic, inflammatory, and redox factors in obese patients. Furthermore, US and CT analysis were performed to visualize the observed images of fatty liver due to obesity. Graphical Keywords: overweight, BMI, obese diabetic patients, iNOS, vanin-1, MCP-1, US, CT Graphical Obesity and insulin resistance (IR) are the components of the metabolic syndrome which is strongly associated with oxidative stress. 1 The most important problem in patients with metabolic syndrome is an increased cardiovascular risk. Oxidative stress is also involved in the pathogenesis of cardiovascular disease. 2 It is worth mentioning that the metabolic syndrome is associated with an increased arterial stiffness and endothelial dysfunction. Perivascular adipose tissue was shown to take part in the pathogenesis of cardiovascular disease. It is also worth mentioning that there are metabolically healthy and metabolically unhealthy obese persons, but a metabolically healthy obesity can change into the metabolically unhealthy state. 3 The establishment of IR is also associated with obesity. 4 In contrast to patients with subcutaneous obesity, people with central obesity exhibit a higher rate of insulin resistance. 5,6 According to some experts, IR is thought to be the primary factor for metabolic and nonmetabolic disorders. 7 Also, Grundy et al 8 reported that the elevated pancreatic insulin production results from peripheral tissue insulin resistance. Hyperinsulinemia provides normal blood glucose levels during this phase. 10 Finally, insulin resistance may outweigh the ability of the pancreas to compensate, and blood glucose levels start to rise. 9 In addition, elevated BMI shows a negative link with HDL-C as well as a positive correlation with TC, LDL-C, and TG levels. 10,11 The link between BMI and lip -Abstract Truncated-

immunology